Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Aged garlic extract: in vitro and in vivo antiallergic effects

Dec. 28, 1998

FDA accepts Hyal's NDA for Solarase

Dec. 23, 1998

Suppression of chemokine production contributes to beneficial dermal effects of tacalcitol

Dec. 22, 1998

Maxim advances development of MaxDerm topical treatment

Dec. 22, 1998

Angiotech initiates another clinical trial with paclitaxel for treatment of psoriasis

Dec. 16, 1998

Antipruritic, immunosuppressive MS-444 derivatives reported by Kyowa Hakko

Dec. 15, 1998

Thalidomide evaluated for toxic epidermal necrolysis and found detrimental

Dec. 10, 1998

Abgenix initiates a phase I/II clinical trial in patients with psoriasis

Dec. 3, 1998

Diane-35 now available in Canada for treatment of acne

Dec. 2, 1998

SA-9499 identified as potent and selective LTA4 hydrolase inhibitor at Santen

Nov. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...